Novo Says Wegovy Injection Reduced BMI and Obesity Rates in Children in Trial
Novo Nordisk said a trial found that Wegovy injections lowered BMI and obesity rates in children.Novo Nordisk said a trial found that Wegovy injections lowered BMI and obesity rates in children. The drug is already approved to treat obesity in children aged 12 and older, while the supplied report says no medications are currently approved for children under 12.
cnbc.com (English) ↗+ Save